Advertisement
If approved, it will be the world’s first DNA vaccine against coronavirus and the fourth to become available in the country.
“The analysis of the phase-three trial data is almost ready and the company has informed the government that it could apply for emergency use licensure for its COVID-19 vaccine next week,” an official source told PTI.
Also, the jab is being tested on children belonging to the age group of 12 to 18 years, apart from adults.
Related Articles
Advertisement
DNA-Plasmid based ZyCoV-D will be a three-dose vaccine and is to be administered intradermally. It can be stored at two to four degrees Celsius and does not require cold chains, making transportation to the remotest parts of the country easy.
The vaccine candidate has been supported by the National Biopharma Mission (NBM) under the aegis of Biotechnology Industry Research Assistance Council (BIRAC), a PSU under the Department of Biotechnology.